Nishil Patel of MMC Ventures explains the firm's research-driven approach to venture capital and EIS investing. With more than 25 years of experience in the venture capital market, MMC focuses on the commercial potential of individual businesses alongside the benefits provided by the EIS structure. Nishil discusses how MMC evaluates investment opportunities, the importance of potential returns and the role of early-stage investments within a broader portfolio. He also addresses the risks investors need to understand, including risk to capital, illiquidity, deployment risk, the J-curve and EIS qualification risk. Watch the full event on-demand: https://us06web.zoom.us/webinar/register/1017829083259/WN_3lPsCebMRvCmdzG3JUKxAA Read more on our website and check out our fund reviews here: https://hardmanandco.com/research/tax-advantaged-research/ Key topics covered: MMC Ventures Research-driven venture capital EIS investing Early-stage technology businesses Commercial investment analysis Risk to capital Portfolio diversification Illiquidity Deployment risk The venture capital J-curve EIS qualification risk HMRC and EIS UK innovation Institutional co-investment September 2026 Tax Advantaged Forum: Nishil Patel, Director and Head of Private Client Fundraising at MMC Ventures, was speaking at Hardman & Co's Tax Advantaged Forum, hosted in association with GrowthInvest. We also heard from EverQuest Capital Partners, Parkwalk and PXN Investments. Important notice: This content has been prepared purely for information purposes, and should not be construed as an offer, or the solicitation of an offer, to buy or sell any security, product, service or investment. Nor should it be viewed as a substitute for viewers’ own due diligence. The companies or legal entities covered in this content may or may not pay us a fixed fee for this content to be made available. This content contains factually correct information at the time of publication which has been provided to us by our client to which the content relates, who have also confirmed that it has not been misleadingly presented. Investing in early-stage growth companies is speculative and involves a high degree of risk. An investor could lose all or a substantial amount of his or her investment, and the securities, legal entities or alternative investments mentioned in this content may not be suitable or appropriate for all investors. Access to liquidity may be totally or highly restricted. Each investor’s particular needs, investment objectives and financial situation were not taken into account in the preparation of this content. Each investor must make his or her own independent decisions and obtain their own independent advice regarding any information, projects, securities, tax treatment or financial instruments mentioned herein. The fact that Hardman & Co has made available through this content various information constitutes neither a recommendation to enter into a particular transaction nor a representation that any financial instrument is suitable or appropriate for you. Each investor should consider whether an investment strategy of the purchase or sale of any product or security is appropriate for them in the light of their investment needs, objectives and financial circumstances. For more information, please read our full disclaimers: www.hardmanandco.com/research-disclosures www.hardmanandco.com/disclaimer #EIS #EISInvesting #VentureCapital #EarlyStageInvesting #TechnologyInvesting #UKInnovation #InvestmentRisk #MMC
